[1]
Hong, H.C.-H., Gooderham, M., Kwatra, S., Gregoriou, S., Yosipovitch, G., Biswas, P., Selfridge, A., Koulias, C. and Güler, E. 2024. Efficacy of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis With Severe Itch at Baseline and in Subgroups by Baseline Thresholds of Severe Itch: A Post Hoc Analysis of the JADE COMPARE and JADE DARE Clinical Trials. SKIN The Journal of Cutaneous Medicine. 8, 2 (Mar. 2024), s380. DOI:https://doi.org/10.25251/skin.8.supp.380.